Home » Topics » Regulatory

Regulatory
RSS

FDA clears Cutivate cream for treatment of atopic dermatitis in children

June 25, 1999

Copley launches first controlled drug

June 24, 1999

U.K. is first market for new formulation of Casodex

June 23, 1999

Botox is not effective in treating whiplash injury

June 17, 1999

Two research teams reach the same conclusion: topiramate is a promising antimigraine agent

June 17, 1999

Leukotriene antagonist effective and well tolerated as migraine prophylaxis

June 16, 1999

Isoprinosine as a potential treatment for chronic fatigue syndrome

June 16, 1999

MORE trial results: raloxifene prevents breast cancer in postmenopausal women

June 16, 1999

Tacrine may reduce symptoms of Tourette syndrome

June 16, 1999

Bisoprolol receives first European approval for chronic heart failure

June 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.